Research programme: human blood coagulation factors - Glycotope/ OctapharmaAlternative Names: FVII-GEX
Latest Information Update: 30 Nov 2015
At a glance
- Originator Glycotope
- Developer Glycotope; Octapharma
- Class Coagulants; Recombinant proteins
- Mechanism of Action Factor VIII stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Haemophilia